Eric Ervin
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$12.9MFederal grants as PI21 awards
1Patents grantedLatest Jul 2, 2019
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
21 awards · $12.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| May 20, 2025 | NIH | STTR Phase I High-Resolution Pseudouridine and m6A Sequencing Through Advanced Nanopore Adduct Analysis | $350K | ELECTRONIC BIOSCIENCES, INC. |
| Mar 19, 2025 | NIH | SBIR Phase I Rapid Fingerstick Diagnostics for Opioid and Stimulant Use Disorders | $386K | ELECTRONIC BIOSCIENCES, INC. |
| Sep 20, 2023 | NIH | SBIR Phase I Nanopores for Processing Proteins | $407K | ELECTRONIC BIOSCIENCES, INC. |
| Aug 30, 2023 | NIH | SBIR Phase I Point-of-Care Assay for Type 1 Diabetes Diagnosis and Prognostication | $285K | ELECTRONIC BIOSCIENCES, INC. |
| Jun 28, 2023 | NIH | SBIR Phase II Nanoscale Tools for Inosine Sequencing | $1.0M | ELECTRONIC BIOSCIENCES, INC. |
| Feb 13, 2023 | NIH | SBIR Phase I Sequencing the Mono-Methylated Derivatives of Cytidine | $400K | ELECTRONIC BIOSCIENCES, INC. |
| Aug 1, 2022 | NIH | SBIR Phase I Dual Reader Protein Sequencing | $394K | ELECTRONIC BIOSCIENCES, INC. |
| Jul 1, 2022 | NIH | SBIR Phase II Nanoscale Tools for Inosine Sequencing | $2.0M | ELECTRONIC BIOSCIENCES, INC. |
| Apr 12, 2022 | NIH | SBIR Phase I Exonuclease Based Microsatellite Sequencing | $400K | ELECTRONIC BIOSCIENCES, INC. |
| Mar 1, 2022 | NIH | SBIR Phase I Comprehensive Botulinum Characterization via the Bilayer Nanowell Integrated Assay | $400K | ELECTRONIC BIOSCIENCES, INC. |
| Sep 1, 2021 | NIH | STTR Phase I Long-lived Platform Development for Exonuclease-Based Sequencing | $400K | ELECTRONIC BIOSCIENCES, INC. with NORTHEASTERN UNIVERSITY |
| Sep 16, 2020 | NIH | SBIR Phase II Exonuclease Epigenetic Sequencing | $897K | ELECTRONIC BIOSCIENCES, INC. |
| May 15, 2020 | NIH | SBIR Phase I N6-Methyl-2'-O-Methyladenosine Sequencing | $400K | ELECTRONIC BIOSCIENCES, INC. |
| Sep 1, 2019 | NIH | SBIR Phase II Exonuclease Epigenetic Sequencing | $1.8M | ELECTRONIC BIOSCIENCES, INC. |
| Aug 31, 2018 | NIH | SBIR Phase II Exonuclease Epigenetic Sequencing | $276K | ELECTRONIC BIOSCIENCES, INC. |
| Aug 24, 2018 | NIH | SBIR Phase I Nanopore Based Exonuclease Enabled DNA Sequencing | $276K | ELECTRONIC BIOSCIENCES, INC. |
| May 15, 2018 | NIH | SBIR Phase II The Bilayer Nanopore Integrated Assay for Complete Toxin Characterization, Phase II | $713K | ELECTRONIC BIOSCIENCES, INC. |
| Jul 15, 2017 | NIH | SBIR Phase II The Bilayer Nanopore Integrated Assay for Complete Toxin Characterization, Phase II | $1.5M | ELECTRONIC BIOSCIENCES, INC. |
| Sep 16, 2016 | NIH | SBIR Phase I Nanopore Enabled Exonuclease Sequencing | $225K | ELECTRONIC BIOSCIENCES, INC. |
| Mar 1, 2015 | NIH | SBIR Phase I Bilayer Nanopore Integrated Assay | $180K | ELECTRONIC BIOSCIENCES, INC. |
| — | NIH | SBIR Phase I NANOSCALE TOOLS FOR RNA MODIFICATION SEQUENCING | $248K | ELECTRONIC BIOSCIENCES, INC. |
1 patents as inventor
- US 10338070ELECTRONIC BIOSCIENCES, INC.Jul 2, 2019
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#37
Awards as PI#21
Patents#284
Companies
- ELECTRONIC BIOSCIENCES, INC.Linked by awards · Medtech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.